Skip to Main Content

Paper Details

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies.
Cancer Cell
90
2022
Author NameAffiliation
Denise M WolfUniversity of California san francisco
Christina YauUniversity of California san francisco
Christina YauUniversity of California san francisco
Amrita BasuUniversity of California san francisco
Amrita BasuUniversity of California san francisco
Minetta C LiuMayo Clinic
William F SymmansUniversity of Texas MD Anderson Cancer Center
Claudine IsaacsLombardi Comprehensive Cancer Center, Georgetown University
Donald A Berry
Lajos PusztaiYale School of Medicine, Yale University
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University
Laura J Van't VeerUniversity of California san francisco
  • 1 - 13

Datasets